All News
EULAR 2023 recommendation for imaging in large vessel vasculitis
Diagnosis of large vessel vasculitis can be challenging, and imaging modalities help with not only the diagnosis but sometimes in assessing flares in the disease. At EULAR 2023, recommendations for imaging modalities for large vessel vasculitis were discussed. These were evidence-based recommendations adapted for practicality in clinical use.
Read Article
EULAR 2023 Notes from Milan (6.09.2023)
Dr. Jack Cush reviews highlight abstracts and sessions - covering lupus, RA, gout, Still's disease, safety data, AI in medicine and more - from last week's EULAR 2023 Congress held in Milan, Italy.
Read Article
Assessing CV Risk in Inflammatory Arthritis: Which Score?
Dr. Aurelie Najm discusses OP0267 presented at EULAR 2023 in Milan, Italy. @AurelieRheumo
https://t.co/qlJ9iMwrip
@AurelieRheumo https://t.co/Yh2siy6555
Links:
Dr. John Cush RheumNow ( View Tweet)
Abatacept: is there a role before RA hits?
Dr. David Liew discusses OP0130 at EULAR 2023 in Milan, Italy. @drdavidliew
https://t.co/SPLOCjjhUt https://t.co/wkPJLz9ctg
Links:
Dr. John Cush RheumNow ( View Tweet)
ANCA-associated vasculitis: beyond therapy with rituximab?
AAV is a group of multi-system autoimmune small vessel vasculitides which includes GPA, MPA and EGPA.
https://t.co/eZ3mgdjrEp https://t.co/dM9B4tVgmr
Links:
Dr. John Cush RheumNow ( View Tweet)
Methotrexate - an old trusted friend who deserves better
MTX has been used as the anchor drug for the treatment of RA and PsA for many years. It has been co-prescribed with biologics and JAKi in clinical trials and as well as in clinical practice.
https://t.co/xp40KklMkA https://t.co/oVqzlQeqbe
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow Eular2023 Coverage - SLE Panel Discussion https://t.co/pLWOqZo2aw https://t.co/itAOjgmMTl
Links:
Dr. John Cush RheumNow ( View Tweet)
AOSD: Young vs. Elderly Onset
AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is considered an orphan disease because of its low prevalence - it is reported anywhere between 16 to 40 per ten million.
https://t.co/fg5TakEvvv https://t.co/lu34gX7WTZ
Links:
Dr. John Cush RheumNow ( View Tweet)
EULAR 2023 Notes from Milan
Dr. Jack Cush reviews highlight abstracts and sessions - covering lupus, RA, gout, Still's disease, safety data, AI in medicine and more - from last week's EULAR 2023 Congress held in Milan, Italy
https://t.co/brcgGv2GHD https://t.co/zVyZkEuLy4
Links:
Dr. John Cush RheumNow ( View Tweet)
Assessing CV Risk in Inflammatory Arthritis: Which Score?
Dr. Aurelie Najm discusses OP0267 presented at EULAR 2023 in Milan, Italy.
https://t.co/MvqkKya4vm
@AurelieRheumo
Links:
Dr. John Cush RheumNow ( View Tweet)
Combining a Tyk2 inhibitor with a JAKi in RA?
Dr. Janet Pope (@Janetbirdope ) weighs in on #EULAR23 abstracts.
https://t.co/7fTZjvnHT3 https://t.co/o43VrWpVpI
Links:
Dr. John Cush RheumNow ( View Tweet)
A step change towards self-empowerment for people living with SLE
As I reflect on my research journey, I recall several issues that still need to be addressed in the management of SLE.
https://t.co/ElunbUgSGF https://t.co/YmA1YWPxVP
Links:
Dr. John Cush RheumNow ( View Tweet)
Postpartum Depression in RA
Dr. Jonathan Kay discusses abstract POS0206-HPR at EULAR 2023 in Milan, Italy.
https://t.co/dzUMIia8Q6 https://t.co/IjeEvz8Cab
Links:
Dr. John Cush RheumNow ( View Tweet)
The Importance of Identifying Central Pain in PsA
Dr. Eric Ruderman discusses abstracts OP0068 and OP0299 at EULAR 2023 in Milan, Italy.
https://t.co/5fjNTrQvNx https://t.co/E1ivkK2bFz
Links:
Dr. John Cush RheumNow ( View Tweet)
Malignancy and CV Risk in Rheumatoid Arthritis
Dr. Jonathan Kay discusses OP0218, OP0219 and OP0211 at EULAR 2023 in Milan, Italy.
https://t.co/o5yrbCBaCb https://t.co/qptUCGb79q
Links:
Dr. John Cush RheumNow ( View Tweet)
JAKi in Rheumatoid Arthritis: Cancer and Cardiovascular Risks
Dr. Antoni Chan discusses abstracts OP0132, POS0831, and OP0133 presented at EULAR 2023 in Milan, Italy.
https://t.co/ApLaPf7uKP https://t.co/nbZgwIlHyb
Links:
Dr. John Cush RheumNow ( View Tweet)
Daily Recap: Day One + Two
https://t.co/USBFbTWzGG https://t.co/RV9RyLLNmX
Links:
Dr. John Cush RheumNow ( View Tweet)
Abatacept: is there a role before RA hits?
Dr. David Liew discusses OP0130 at EULAR 2023 in Milan, Italy.
https://t.co/XJXabAULhn https://t.co/Hv93HKolKH
Links:
Dr. John Cush RheumNow ( View Tweet)
Among 247.3 million US adults. 10.0% (20.3 million) had CVD & 56% were at risk for CVD. Yet only 3.6 million CVD (18%) & 34.5 million at risk for CVD (26%) used wearable devices (compared to 29% in US adults, but less than half wear every day. https://t.co/04xqtkw61x https://t.co/ETTjamvHi2
Links:
Dr. John Cush RheumNow ( View Tweet)
Watch: Zoster Management and Vaccination
Drs. Janet Pope and Kevin Winthrop at EULAR 2023 in Milan, Italy.
https://t.co/eOhXzw3Epy https://t.co/h3NoDggg5x
Links:
Dr. John Cush RheumNow ( View Tweet)
